Objectives: To compare the clinical profile and short-term outcome of children admitted with acute SARS-CoV-2 infection during the first and second waves of the Coronavirus Disease (COVID-19).
Methods: This retrospective study was conducted in a tertiary care setting. A retrospective medical record review of all pediatric patients admitted with confirmed SARS-CoV-2 infection between March 2020 and September 2021 was conducted.
Objective: To study the clinical profile and outcome of children with MIS-C treated with methylprednisolone pulse therapy and /or intravenous immunoglobulin (IVIG).
Method: This prospective observational study included children satisfying CDC MIS-C criteria admitted from September to November, 2020. Primary outcome was persistence of fever beyond 36 hours after start of immunomodulation therapy.
Background: Safety-pin ingestion causing cardiovascular complications are very rare with high risk for mortality.
Case Characteristics: A 10-month-old child who presented with persistent irritability and intermittent fever of 1 month duration. The child had tachypnea and mild subcostal retractions.